Manuscripts
Showing 1591 manuscripts.
Human immunodeficiency virus type 1 RNA shedding in the female genital tract
Citation
Claudia Goulston, M.D., W. McFarland, David Katzenstein, M.D. Human immunodeficiency virus type 1 RNA shedding in the female genital tract. Journal of Infectious Diseases. 1998 Apr 01; 177(4):1100-3.Year
1998
Journal
Journal of Infectious Diseases
Interlaboratory concordance of DNA sequence analysis to detect drug reverse transciptase mutations in HIV-1 proviral DNA
Citation
Lisa M. Demeter, Richard D'Aquila, Owen Weislow, Alejo Erice, Joseph Fitzgibbon, Robert Shafer, Douglas Richman, Yuqi Zhao, Diana Huang, Douglas Mayers, Max Arens, Kim Sannerud, Suraiya Rasheed, Daniel Kuritzkes, Patricia Reichelderfer, Anthony Japour. Interlaboratory concordance of DNA sequence analysis to detect drug reverse transciptase mutations in HIV-1 proviral DNA. Journal of Virological Methods. 1998 Nov 01; 75(1):93-104.Year
1998
Journal
Journal of Virological Methods
Genotypic and phenotypic characterization of Cryptosporidium parvum isolates from people with AIDS
Citation
G. Widmer, S. Tzipori, Carl J. Fichtenbaum, M.D., Jeff Griffiths, M.D., MPHTM. Genotypic and phenotypic characterization of Cryptosporidium parvum isolates from people with AIDS. Journal of Infectious Diseases. 1998 Sep 01; 178(3):834-40.Year
1998
Journal
Journal of Infectious Diseases
Maternal Viral Genotypic Zidovudine Resistance and Infrequent Failure of Zidovudine Therapy to Prevent Perinatal Transmission of HIV-1 in Pediatric AIDS Clinical Trials Group Protocol 076
Citation
P. S. Eastman, David E. Shapiro, Robert W. Coombs, Lisa M. Frenkel, George D. McSherry, Paula Britto, Steven A. Herman, Ph.D., Rhoda S. Sperling. Maternal Viral Genotypic Zidovudine Resistance and Infrequent Failure of Zidovudine Therapy to Prevent Perinatal Transmission of HIV-1 in Pediatric AIDS Clinical Trials Group Protocol 076. Journal of Infectious Diseases. 1998 Mar 01; 177:557-64.Year
1998
Journal
Journal of Infectious Diseases
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
Citation
Frank Palella, M.D., K. M. Delaney, A. C. Moorman, Mark O. Loveless, M.D., Jack Fuhrer, M.D., G. A. Satten, D. J. Aschman, S. D. Holmberg. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine. 1998 Mar 26; 338(13):853-60.Year
1998
Journal
New England Journal of Medicine
Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor
Citation
David J. Straus, M.D., Jenny Huang, M.S., Marcia A. Testa, M.P.H., Ph.D., Alexandra M. Levine, M.D., Lawrence D. Kaplan, M.D. Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. Journal of Clinical Oncology. 1998 Nov 01; 16(11):3601-6.Year
1998
Journal
Journal of Clinical Oncology
Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 trial group
Citation
Genevieve Chene, Philippe Morlat, M.D., Catherine Leport, M.D., Richard Hafner, M.D., L. Dequae, I. Charreau, Jean-Pierre Aboulker, Ph.D., Benjamin J. Luft, M.D., Jean Aubertin, Jean-Louis Vilde, Roger Salamon. Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 trial group. Controlled Clinical Trials. 1998 Jun 01; 19(3):233-48.Year
1998
Journal
Controlled Clinical Trials
Safety of the Maternal-Infant Zidovudine Regimen Utilized in the Pediatric AIDS Clinical Trial Group 076 Study
Citation
Rhoda S. Sperling, M.D., David E. Shapiro, Ph.D., George D. McSherry, M.D., Paula Britto, M.S., Bethann Cunningham-Schrader, B.A., M.S., Mary Culnane, C.R.N.P., M.S., Robert W. Coombs, M.D., Ph.D., Gwendolyn B. Scott, M.D., Russell B. Van Dyke, M.D., William T. Shearer, M.D., Ph.D., Eleanor Jimenez, M.D., F.A.A.P., Clemente Diaz, M.D., Duane Harrison, M.D., Jean-Francois Delfraissy, M.D. Safety of the Maternal-Infant Zidovudine Regimen Utilized in the Pediatric AIDS Clinical Trial Group 076 Study. AIDS. 1998 Oct 01; 12(14):1805-13.Year
1998
Journal
AIDS
Safety and Immunogenicity of HIV Recombinant Envelope Vaccines in HIV-infected Infants and Children
Citation
JS Lambert, J McNamara, SL Katz, T Fenton, MH Kang, TC VanCott, R Livingston, E Hawkins, J Moye, W Borkowsky, D Johnson, R Yogev, AM Duliege, Donald P. Francis, M.D., D.Sc., Anne A. Gershon, M.D., Diane W. Wara, M.D., Natasha L. Martin, Myron Levin, M.D., George D. McSherry, M.D., Gale Smith, Ph.D. Safety and Immunogenicity of HIV Recombinant Envelope Vaccines in HIV-infected Infants and Children. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998 Dec 15; 19(5):451-61.Year
1998
Journal
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
The extent of non-adherence in a large clinical trial using plasma dideoxynucleoside concentrations as a marker
Citation
Helen Kastrissios, J. R. Suarez, Scott M. Hammer, M.D., David Katzenstein, M.D., Terrence F. Blaschke, M.D. The extent of non-adherence in a large clinical trial using plasma dideoxynucleoside concentrations as a marker. AIDS. 1998 Dec 03; 12(17):2305-11.Year
1998
Journal
AIDS